Ajuste Direto para a aquisição de R147 - RITUXIMAB [100 MG/ 10 ML; FRS], R148 - RITUXIMAB [500 MG/ 50 ML; FRS] e T1585 - TRASTUZUMAB [150 MG; PÓ P/ CONC P/ SOL P/ PERF; FRS] DOENTES EM TRATAMENTO

ID 6065686 · Portal BASE
Price
Base Price
€317,803 .00
Effective Price
€24,595 .00 -92.3%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Coimbra, Figueira da Foz
Bidder Count
—
Winner
PHARMAKERN PORTUGAL, LDA.
NIF 507002571
Company
Dates
Publication
28 Nov 2019
Celebration
10 Sep 2019
Contracting Entity
Unidade Local de Saúde do Baixo Mondego, E. P. E.
NIF 506361527
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 100 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
278
Supplier
309
Number of Awards
5
Rule
A1 repeat direct award: 5 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
28 Nov 2019
Signing Date
10 Sep 2019
Days Late
79
Rule
A2/A3 late publication: 79 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
317803.0
Total effective price
24595.0
Ratio
0.0774
Direction
reduction
Rule
A9 price reduction: ratio 0.0774 outside [0.5, 1.5]
Detected 2026-03-06